Exploring SRAX, Inc. (SRAX) Investor Profile: Who’s Buying and Why?

Exploring SRAX, Inc. (SRAX) Investor Profile: Who’s Buying and Why?

US | Communication Services | Advertising Agencies | NASDAQ

SRAX, Inc. (SRAX) Bundle

Get Full Bundle:
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$24.99 $14.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99
$14.99 $9.99

TOTAL:

You're looking at SRAX, Inc. and trying to figure out who is actually holding the shares, because the ownership structure here is defintely not standard. The quick takeaway is that this stock is overwhelmingly driven by retail and public investors, not the big funds; institutional ownership is shockingly low, sitting at only about 0.29% of the total shares outstanding as of mid-2025. Think about that: out of roughly 29.44 million total shares, public and retail investors own a massive 99.92%, or about 29.42 million shares.

This dynamic creates a fundamentally different risk profile than a stock heavily owned by BlackRock or Vanguard, even with a forecasted annual revenue of $95 million and an Earnings Per Share (EPS) of $0.50 for the full 2025 fiscal year. When The Vanguard Group, Inc. holds only 6,885 shares, and the entire institutional base is that small, volatility can be extreme. So, how does a company with a 2025 market capitalization of just $9.3 million manage to forecast that revenue, and what does this retail-heavy shareholder base mean for your investment strategy? Let's dig into who is buying, who is selling, and whether that $0.32 stock price, as of March 2025, is a floor or just a stop on the way down.

Who Invests in SRAX, Inc. (SRAX) and Why?

The investor base for SRAX, Inc. (SRAX) is primarily composed of individual, or retail, investors who are betting on a massive turnaround in the company's financial trajectory, a strategy common in micro-cap stocks. The stock's current market capitalization of just $9.3 million as of March 2025, combined with its over-the-counter (OTC) listing, means it sits outside the typical mandate of most large institutional funds.

Key Investor Types: A Retail-Driven Stock

When you look at SRAX, Inc.'s ownership structure, you see a clear picture of a company heavily reliant on the general public. This is a classic small-cap scenario: the stock is too small and often too volatile for the big money to commit significant capital. Institutional ownership is minimal, with only one institutional owner filing a 13F form and holding a total of just 3,374 shares, according to recent data.

Here's the quick math: with a market cap this low, the dominant shareholders are insiders, small hedge funds taking a high-risk position, and, most importantly, the retail crowd. Older data suggests the general public has historically held a substantial stake-as high as 56% to 86%-and while a precise 2025 figure is hard to pin down, the current low market cap and high trading volume relative to its float confirm that retail investors drive the price action. They are the ones who collectively influence decisions like dividend policies or major corporate actions.

  • Retail Investors: The largest, most active shareholder group.
  • Institutional Holders: Minimal presence, often limited to index or extended market funds.
  • Hedge Funds: Historically small stakes, focused on short-term catalysts or activist roles.

Investment Motivations: The Turnaround Story

The primary motivation for buying SRAX, Inc. in 2025 is a belief in the company's strategic pivot and its massive forecasted growth, not current performance. The company has focused its business entirely on its core financial technology platform, Sequire, which provides investor intelligence and communications tools for publicly traded companies.

Investors are looking past the recent financial challenges, such as the revenue decline seen in 2023, and are instead focused on the projected financial rebound. The forecasted numbers for the 2025 fiscal year are the main catalyst, painting a picture of a company on the cusp of profitability and scale. This is a pure growth play.

2025 Financial Forecast (FY) Value Context
Forecasted Annual Revenue $95 Million A massive jump from the trailing 12-month revenue of $18.6M in mid-2023.
Forecasted Annual EPS (Earnings Per Share) $0.50 per share Indicates a significant return to profitability.
Stock Price (March 2025) $0.32 per share Suggests a huge upside if forecasts are met.

The entire investment thesis hinges on the successful execution of the Sequire platform's expansion and the company's ability to raise additional capital to fund operations. Investors are buying the future, not the present. You can read more about the long-term vision in the Mission Statement, Vision, & Core Values of SRAX, Inc. (SRAX).

Investment Strategies: High-Risk, High-Reward Speculation

Given the low stock price and the enormous disparity between the current market cap and the 2025 revenue forecast, the dominant strategy among SRAX, Inc. investors is speculative growth investing. This is not a dividend stock-it does not pay one-nor is it a stable, long-term holding for a conservative portfolio.

The low share price of $0.32 as of March 2025 attracts short-term traders looking for volatility and quick gains, especially if the company announces a major client win or a successful capital raise. Others are engaging in a classic value investing approach, believing the stock is deeply undervalued relative to the forecasted $0.50 EPS. Honsetly, if that EPS number comes true, the stock price defintely has room to run.

  • Speculative Growth: Buying based on the massive forecasted revenue and EPS, expecting a multi-bagger return.
  • Short-Term Trading: Exploiting the high volatility typical of micro-cap stocks.
  • Activist Investing: Small hedge funds may take positions to push for operational changes or a sale of the company.

Institutional Ownership and Major Shareholders of SRAX, Inc. (SRAX)

The institutional investor profile for SRAX, Inc. (SRAX) is extremely concentrated and small, which tells you a lot about the company's current market position as an Over-The-Counter (OTC) stock. Your direct takeaway here is that institutional money has largely stayed on the sidelines, meaning the stock's price action is driven primarily by retail traders and insiders, not the big funds.

Top Institutional Investors and Holdings

As of the most recent filing date on June 30, 2025, SRAX, Inc. reported a remarkably low level of institutional participation. The company had only 1 institutional owner that filed a 13F form with the Securities and Exchange Commission (SEC). This single entity holds a passive, almost negligible stake in the company.

The one institutional owner is an index fund, which means the holding is not a conviction-based, active investment but rather a requirement to track a specific market index. Honestly, this is a common pattern for smaller, illiquid stocks trading on the OTCPK (Pink Sheets) with a small market capitalization (cap).

Here's the quick math on the top (and only) institutional holder:

Institutional Investor Shares Held (as of 06/30/2025) Type of Holding
USMIX - Extended Market Index Fund 3,374 Passive Index Fund

To put this in perspective, SRAX, Inc.'s total shares outstanding were approximately 29.2 million as of March 26, 2025, with a market cap of only $9.3 million. The total institutional shares of 3,374 represent a fraction of a percent of the company, which is defintely not a sign of Wall Street conviction. You can learn more about the company's core business, which centers on its Sequire investor intelligence platform, by reviewing SRAX, Inc. (SRAX): History, Ownership, Mission, How It Works & Makes Money.

Changes in Institutional Ownership: A Flat Line

The trend in institutional ownership for SRAX, Inc. has been essentially flat in the near term. For the most recent quarter ending June 30, 2025, the total number of institutional shares held remained unchanged, showing a 0.00% change from the prior quarter. This lack of movement is a key signal.

When you see zero change, it means the big money isn't actively buying or selling, which often points to a few things:

  • Low Liquidity: The stock may not have enough trading volume to support large institutional purchases or sales without moving the price too much.
  • Investment Mandate: The single index fund holder is simply maintaining its mandated position to track the index, not making a strategic investment decision.
  • OTC Status: Many larger funds, including BlackRock and others, have internal rules that prevent them from holding or initiating positions in OTC-traded stocks like SRAX, Inc.

The institutional accumulation score, which tracks buying trends, would naturally be low here because there is no significant buying activity to report. It's a retail-heavy stock.

Impact of Institutional Investors on Strategy and Stock Price

The role of institutional investors in SRAX, Inc.'s stock price and corporate strategy is minimal. In a typical NASDAQ or NYSE-listed company, a BlackRock or Vanguard holding 5% or more of the shares can exert significant influence on management decisions, especially around capital allocation or mergers. That's not the case here.

With only a single, passive index fund holding 3,374 shares, there is no institutional pressure on the board or management. The company's strategic direction, particularly its focus on its Sequire platform, is driven almost entirely by its executive team and private shareholders, not by the demands of a large institutional base.

For you as an investor, this means a few things:

  • Higher Volatility Risk: The stock price is more susceptible to the sentiment and trading activity of individual retail investors, leading to higher volatility.
  • Limited Oversight: You don't have the implicit oversight and due diligence that comes from major institutions scrutinizing a company's financials and governance.
  • Focus on Fundamentals: Your investment decision must rely heavily on the company's core business performance and its ability to generate revenue-which was $18.6 million (trailing 12 months as of June 30, 2023)-rather than on the confidence of major Wall Street players.

The lack of institutional interest is a risk you must factor into your valuation model.

Key Investors and Their Impact on SRAX, Inc. (SRAX)

The investor profile for SRAX, Inc. (SRAX) is highly unusual for a publicly traded company, as it is overwhelmingly dominated by retail investors and insiders, not large institutional funds. This means the stock's movement and the company's direction are far more susceptible to the collective actions of individual shareholders than to the typical Wall Street giants.

As of mid-2025, the composition of the shareholder base shows that Public Companies & Retail Investors hold a staggering 99.92% of the shares outstanding. Institutional ownership is negligible, which is why you won't see BlackRock or Vanguard holding a dispositive (controlling) stake here. This low institutional float is a double-edged sword: it means the stock is less insulated from volatility, but it also gives individual investors an outsized influence on governance and price action.

  • Retail investors drive 99.92% of the ownership.
  • Institutional holdings are extremely small, under 1% of the total float.
  • The low market cap of $9.3 million (March 2025) keeps it off most major fund radars.

The Few Institutional Holders and Their Passive Role

The few institutional investors that do appear on the register are mostly passive index funds. They are buying SRAX, Inc. (SRAX) not because of a deep-dive valuation, but simply because the stock is part of a micro-cap index they track.

For example, as of August 2025, iShares Trust - iShares Micro-Cap ETF is the largest institutional holder, with only 49,878 shares, representing a mere 0.17% of the company. Dimensional Fund Advisors LP holds another 17,131 shares (0.06%). These funds are not activist investors; they are simply following their mandate. Their impact is minimal, so you can't rely on them to push for operational changes. The real power rests with the retail base and the company's own management.

Top Institutional Holders (Mid-2025) Shares Held % of Holding
iShares Trust - iShares Micro-Cap ETF 49,878 0.17%
Dimensional Fund Advisors LP 17,131 0.06%
The Vanguard Group, Inc. 6,885 0.02%

Insider Stakes and Recent Major Moves

In a company with such a small institutional presence, insider ownership becomes a much more important signal. CEO Christopher Miglino, for instance, held 902,575 shares (1.7% ownership) as of late 2023, with a notable buy of 15,000 shares at $0.05 per share in December 2023. This level of ownership, while not a majority, is significant in a micro-cap environment and suggests management's interests are aligned with shareholders. Honestly, in a stock this small, insider buys are often the most defintely bullish signal you can get.

A recent, highly relevant event is the Schedule 13D filing on October 7, 2025, with an amendment on October 8, 2025. A Schedule 13D is filed when an investor, often an activist, acquires beneficial ownership of more than 5% of a company's stock and intends to actively influence management or strategy. This move signals that a new, potentially influential shareholder has arrived. Given the low institutional float, any new 5%+ holder will have a disproportionate impact on the stock's future trajectory and the company's strategic decisions, especially as SRAX, Inc. (SRAX) is forecasted to hit $95 million in revenue for the 2025 fiscal year.

Investor Influence: Why Retail Matters Here

The core takeaway for SRAX, Inc. (SRAX) is that its investor influence is bottom-up. Because institutional money has largely stayed away, the collective will of the public/retail investors holds sway. This group can influence everything from voting on key proposals to creating significant price swings on low trading volume. The stock's price of $0.32 per share (March 2025) is more sensitive to retail sentiment and news flow-like the company's Sequire platform, which is its primary revenue generator-than to traditional analyst coverage. Understanding the company's core business, which is a financial technology platform for public companies, is essential to understanding the retail investor's belief in its future. You can read more about the company's background here: SRAX, Inc. (SRAX): History, Ownership, Mission, How It Works & Makes Money.

Here's the quick math: with a forecasted EPS of $0.50 for 2025, the market is pricing in a significant growth story or a major turnaround, and the retail base is the one betting on that outcome. The recent 13D filing suggests a new, large player is also seeing that opportunity and is ready to push for value creation.

Next Step: Track the details of that October 7, 2025 Schedule 13D filing to understand the new shareholder's intentions-that's where the near-term risk and opportunity truly lies.

Market Impact and Investor Sentiment

You're looking at SRAX, Inc. (SRAX) and trying to figure out who's still in the game and why. The direct takeaway is that institutional conviction is near non-existent, and the market sentiment is overwhelmingly negative, despite some aggressive analyst forecasts for 2025. The stock's performance tells the real story.

As of late 2025, the institutional investor base for SRAX is incredibly thin. We're talking about only 1 institutional owner, which is the USMIX - Extended Market Index Fund, holding a tiny position of just 3,374 shares as of September 26, 2025. This is defintely not a sign of major institutional support. When professional money managers are this absent, it signals a significant lack of confidence in the near-term outlook or the company's ability to execute its strategic shift toward its Sequire SaaS platform.

Major shareholders, often company insiders or long-term private investors, are the key players here, not the institutions. Back in 2023, SRAX formed an Advisory Board with four of its largest shareholders, who collectively own millions of shares. Their sentiment is tied to the success of the strategic shift-optimizing the balance sheet and reducing reliance on marketable securities. But, to be fair, holding a stock that has dropped this much is a tough situation for anyone.

  • Institutional money is largely sitting on the sidelines.
  • Retail investors and insiders drive the current ownership structure.
  • Low institutional float means high volatility risk.

Recent Market Reactions to Ownership Shifts

The stock market's reaction to SRAX, Inc.'s recent history has been brutal, completely overshadowing any minor ownership changes. The numbers speak for themselves: the stock has seen a year-to-date change of a staggering -95.7%. That's a catastrophic loss of market value, which has pushed the stock price down to around $0.01, a sharp decline from the $0.32 price point it held in March 2025. The 52-week trading range of $0.001 to $0.380 shows extreme volatility, which is typical for a company with a market capitalization that has shrunk to approximately $9.3 million.

Here's the quick math: a stock dropping over 95% YTD means any large-scale selling by a major shareholder, even an insider, would likely be a desperate move to liquidate a rapidly depreciating asset, not a strategic exit. The market is reacting to the company's financial health, which you can dig into further in Breaking Down SRAX, Inc. (SRAX) Financial Health: Key Insights for Investors. The negative price momentum is so strong that any small institutional position change, like the removal of StoneX Group Inc.'s position, barely registers against the backdrop of this decline.

Analyst Perspectives: A Disconnect

The analyst community presents a strange, almost disconnected picture. While comprehensive, current analyst forecasts for SRAX are largely unavailable, the remaining data points show a massive gulf between historical optimism and current reality. The consensus rating is technically a 'Buy' (based on old reports), but this is a ghost rating, as the firms providing it have not updated their targets since 2023 or earlier.

However, some 2025 forecasts do exist, and they are highly aggressive, suggesting a huge turnaround. For the fiscal year ending December 31, 2025, the forecasted annual revenue is an ambitious $95 million, with an earnings per share (EPS) forecast of $0.50. This is a massive leap from the trailing twelve-month (TTM) revenue of approximately $18.6 million as of mid-2023. What this estimate hides is the significant operational challenges SRAX faces, including a sharp revenue decline due to a shift to a cash-only payment model.

The analyst perspective, or lack thereof, on the impact of key investors is simple: there is no key institutional investor driving the narrative. The company's future hinges on its internal strategic shift and management's ability to turn the Sequire platform into a consistent, high-margin revenue generator, not on a BlackRock-sized investment. The market is waiting for proof of execution, not a new 13F filing.

Metric Value (FY 2025 Data) Implication
Market Capitalization ~$9.3 million (Mar 2025) Micro-cap status, high risk, low liquidity.
YTD Stock Change -95.7% Extreme negative market reaction/sentiment.
Largest Institutional Holding 3,374 shares (USMIX, Sep 2025) Institutional interest is negligible.
Forecasted Annual Revenue (2025) $95 million Aggressive target, requires massive execution turnaround.
Forecasted EPS (2025) $0.50 Suggests a return to profitability, highly speculative.

The key action for you is to ignore the old 'Buy' ratings and focus on the company's Q3 2025 results when they drop, specifically looking for concrete evidence that the revenue and cost management improvements mentioned in the April 2025 strategic update are actually materializing.

DCF model

SRAX, Inc. (SRAX) DCF Excel Template

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support


Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.